Sharma, K., C. Weber, M. Bairlein, Z. Greff, G. Keri, J. Cox, J. V. Olsen and H. Daub: Proteomics strategy for quantitative protein interaction profiling in cell extracts. In: Nature Methods 6, 10, 741-744 (2009).
Oppermann, F. S., F. Gnad, J. V. Olsen, R. Hornberger, Z. Greff, G. Keri, M. Mann and H. Daub: Large-scale Proteomics Analysis of the Human Kinome. In: Molecular & Cellular Proteomics 8, 7, 1751-1764 (2009).
Keri, G., L. Orfi, Z. Greff, Z. Varga, B. Szokol, Z. Horvath, I. P. Petak and A. Ullrich: SIGNAL TRANSDUCTION THERAPY OF TUMORS WITH MULTIPLE TARGET KINASE INHIBITORS. In: Anticancer Research 28, 5C, (2008).
Daub, H., J. V. Olsen, M. Bairlein, F. Gnad, F. S. Oppermann, R. Körner, Z. Greff, G. Keri, O. Stemmann and M. Mann: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. In: Molecular Cell 31, 3, 438-448 (2008).
Keri, G., L. Orfi, D. Eros, B. Hegymegi-Barakonyi, C. Szantai-Kis, Z. Horvath, F. Waczek, J. Marosfalvi, I. Szabadkai, J. Pato, Z. Greff, D. Hafenbradl, H. Daub, G. Muller, B. Klebl and A. Ullrich: Signal transduction therapy with rationally designed kinase inhibitors. In: Current Signal Transduction Therapy 1, 1, 67-95 (2006).
Kéri, G., Z. Székelyhidi, Z. Bánhegyi, Z. Varga, B. Hegymegi-Barakonyi, C. Szántai-Kis, D. Hafenbradl, B. Klebl, G. Müller, A. Ullrich, D. Erös, Z. Horváth, Z. Greff, J. Marosfalvi, J. Pató, I. Szabadkai, I. Szilágyi, Z. Szegedi, I. Varga, F. Wáczek and L. Örfi: Drug discovery in the kinase inhibitory field using the nested chemical libraryTM technology. In: Assay and Drug Development Technologies Assay Drug Dev. Technol., 543-552 (2005).
Blencke, S., B. Zech, O. Engkvist, Z. Greff, L. Orfi, Z. Horvath, G. Keri, A. Ullrich and H. Daub: Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors. In: Chemistry & Biology 11, 5, 691-701 (2004).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.